Fierce Pharma

JANUARY 4, 2024

The Seattle-based CDMO has unveiled its plan to construct a four-story complex, which will cover 20,000 square meters (215,000 square feet) and is expected to become operational in 2026.

Manufacturing 254

Manufacturing 254

Fierce Pharma

MARCH 7, 2024

By Eisai’s 2026 fiscal year—which ends in March 2027—the company figures its Alzheimer's disease drug Leqembi can bring home 290 billion Japanese yen (nearly $2 billion) in global revenues. Come fiscal year 2032, those sales could potentially swell to a whopping 1.3 trillion yen ($8.8 billion).

Sales 208

Sales 208

Fierce Pharma

OCTOBER 9, 2023

billion) for exclusive rights to distribute the shingles shot in China from 2024 through 2026. GSK has forged a partnership with vaccine powerhouse Chongqing | GSK has forged a partnership with vaccine powerhouse Chongqing Zhifei Biological Products to distribute Shingrix in China. Zhifei will pay £2.5 billion ($3.05

Distribution 277

Distribution 277

Fierce Pharma

SEPTEMBER 5, 2023

The case was filed Friday in New Jersey federal court, three days after the CMS revealed that Novartis’ heart failure treatment Entresto was among 10 drugs subject to price negotiations in 2026.

Biopharma 290

Biopharma Government 290

Fierce Pharma

OCTOBER 27, 2023

In August, Imbruvica was one of the 10 drugs identified by the CMS that will be subject to price negotiations in 2026. . | Sales of AbbVie and Johnson & Johnson’s leukemia blockbuster Imbruvica are taking a hit from BeiGene’s Brukinsa. But what about the impact of the Inflation Reduction Act?

Sales 241

Sales 241

Fierce Pharma

DECEMBER 14, 2023

Ahead of 2026’s Medicare drug price negotiations, the White House is getting ready to crack down on companies who’ve raised the costs of their medications faster than the rate of inflation.

Medical 199

Medical 199

World of DTC Marketing

FEBRUARY 22, 2021

billion by 2026. The post Jazz Pharma uses flying pig for huge grey area DTC appeared first on World of DTC Marketing.com. One of the most common complaints people have is “lack of energy” Consumers have turned to energy drinks which was valued at $53.01 This DTC is an embaressment.

Pharma 181

Pharma Doctors Side effects Prescription 181

Pharmaceutical Technology

JULY 26, 2022

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). The deal will make NewAmsterdam Pharma a publicly listed company focusing on oral treatments for cardiometabolic diseases.

Pharma 59

Pharma Specialization Healthcare Healthcare 59

pharmaphorum

JANUARY 10, 2023

Its ability to accelerate R&D programmes, energise real-time clinical decision making and sharpen connections between pharma organisations and clients is clear and they can combine to positively impact patient outcomes. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

Clarivate

OCTOBER 31, 2023

These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. Big pharma is still keen to access good technology, science, and assets, in many cases to plug a patent-expiry-shaped hole in their coffers. In short, the biotech bubble had burst. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Of the 50 leading companies in the pharma industry, U.S. Centers for Disease Control and Prevention had the most mentions of internet of things in Q1 2023.

Media 52

Media Pharma Competition Marketing 52

European Pharmaceutical Review

APRIL 15, 2024

MaaT Pharma stated that this represents “the highest overall survival” in patients with aGvHD when compared to reported evidence in the literature (Abedin et al., Advancing microbiome innovation As third line treatment, MaaT013 facilitated a 63 percent gastrointestinal overall response rate (GI-ORR) at D28 and 53 percent at D56.

Pharma 74

Pharma Patients Management Leads 74

MedCity News

MAY 15, 2023

The royalty deal extends uniQure’s cash runway into 2026. By selling partial royalties to approved hemophilia gene therapy Hemgenix, uniQure gains immediate cash to support its pipeline, including a Huntington’s disease gene therapy already in the clinic.

Biopharma 113

Biopharma Pharma 113

pharmaphorum

SEPTEMBER 30, 2022

7,326,708) was challenged by Mylan Pharma, now Viatris, before the US Patent and Trademark Office (USPTO), which ruled in Merck’s favour last year. That challenged the ‘708 patent – which expires in November 2026 – as well as one other (No. The US patent (No.

Marketing 57

Marketing Sales Competition FDA 57

European Pharmaceutical Review

MARCH 13, 2023

Full operations is provisionally planned for late 2026. Articles: Interchangeability of biosimilars in the EU – the industry impact… UPC opt-out – a strategic balancing act for pharma… The post Sandoz to build biologics plant in Slovenia appeared first on European Pharmaceutical Review.

Networking 81

Networking Competition Pharma Pharmaceutical 81

European Pharmaceutical Review

MAY 25, 2023

Tara Dougal, Content Director of Pharma at Informa explained that each category in 2024 Exhibitor Awards “requires an implicit sustainability focus, we hope to encourage pharma companies and product developers to consider sustainability and environmental impact at each stage of the development process”.

Distribution 72

Distribution Pharma Pharmaceutical Patients 72

Pharmaceutical Technology

APRIL 10, 2023

India-based pharmaceutical company Cipla has entered into a perpetual licence agreement with Swiss drugmaker Novartis Pharma for the diabetes drug Galvus and its combination brands. Under the deal, Cipla will be responsible for the manufacturing and marketing of Galvus and its combination brands from 1 January 2026.

Manufacturing 52

Manufacturing Medicine Pharma Sales 52

pharmaphorum

OCTOBER 14, 2022

A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The project started on 1 October and is scheduled to complete in September 2026.

Leads 118

Leads Electronics Ethics Healthcare 118

pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. Ipsen’s CVR offer includes $0.30

Biopharma 91

Biopharma Sales Prescription FDA 91

World of DTC Marketing

OCTOBER 27, 2020

Our healthcare system makes too much money for insurers, PBM’s and pharma companies to change. By 2026, national health expenditures will reach $5.7 It’s simple: people trust each other more than pharma companies who they view with a high degree of skepticism. It’s a good read but ignores a simple fact.

Healthcare 230

Healthcare Healthcare Insurance Retail 230

pharmaphorum

JANUARY 18, 2023

NewAmsterdam Pharma’s bold play to resurrect an all-but defunct cholesterol-lowering drug class has been rewarded with a positive phase 2 trial of its oral CETP inhibitor obicetrapib. Amgen licensed the rights to NewAmsterdam in 2020.

Pharma 57

Pharma Prospecting Patients Safety 57

European Pharmaceutical Review

MAY 11, 2023

Delivering end-to-end expertise and solutions from research discovery to development, and diagnosis to cure, Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech , diagnostic labs, academia and government agencies. Register here.

Government 77

Government Prospecting Media Marketing 77

pharmaphorum

AUGUST 5, 2022

Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring two new cancer therapies as quickly as possible to patients in the world’s second-largest pharma market.

Side effects 83

Side effects Marketing Pharma Medicine 83

pharmaphorum

JULY 26, 2022

NewAmsterdam Pharma has charted out a route to a Nasdaq listing by merging with black cheque company Frazier Lifesciences in a deal that will provide additional cash for its main drug candidate – oral CETP inhibitor obicetrapib. Remember CETP? Amgen licensed the rights to NewAmsterdam in 2020.

Side effects 52

Side effects Safety Pharma Patients 52

PM360

SEPTEMBER 21, 2023

The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen. Starting in 2026, the provision will affect 10 Part D drugs. Casberg said his company is getting many queries from payers and PBMs about these issues.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

JANUARY 18, 2023

German pharma group Bayer has made another play in the digital medical imaging category, buying Blackford Analysis and its artificial intelligence-based platform for radiological assessments.

Medical 57

Medical Pharma Media Sales 57

Pharma Leaders

MAY 12, 2023

The company will initially buy a 60% interest in Nutrasource while having the right to pick the remaining 40% holding in 2026. Swiss company SGS has purchased a majority stake in Nutrasource Pharmaceutical and Nutraceutical Services as well as its subsidiaries (Nutrasource). Financial terms of the transaction were not shared.

Pharmaceutical 52

Pharmaceutical Management Marketing 52

pharmaphorum

DECEMBER 21, 2022

Since September, it has been led by president and CEO Sujay Kango – also on the boards of MEI Pharma and Infinity Pharma – who has no doubt focused his attentions on getting the Kite deal over the line since taking on the role.

Pharma 52

Pharma Manufacturing Engineering Safety 52

pharmaphorum

NOVEMBER 25, 2022

German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan’s Kyowa Kirin, which are currently sold by affiliate companies across Europe.

Medicine 52

Medicine Marketing Pharma Management 52

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Pharma manufacturers of brands that are selected for negotiation will absolutely want to ‘pull through’ their coveted, newfound formulary position with HCPs.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PM360

APRIL 7, 2023

Dan Renick The IRA presents market access teams with a unique opportunity to make recommendations to CMS regarding the evidence and methodology that will be applied in evaluating drugs for upcoming Medicare negotiations that will lead to price adjustments in 2026. Quality and value measurements commonly used outside of the U.S.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

pharmaphorum

SEPTEMBER 23, 2022

Chances of FDA approval for Spectrum Pharma’s lung cancer candidate poziotinib and Oncopeptides’ Pepaxto for multiple myeloma have taken a dive, after the regulator’s expert advisors voted that the drugs were not ready to reach the market.

FDA 52

FDA Patients Marketing Pharma 52

PM360

SEPTEMBER 21, 2023

Our solutions enable pharma manufacturers to engage with providers and patients so they can start and stay on the right medication and improve their health outcomes. We often say that our platform enables pharma brands across all specialties to “reach the audience they want at the scale they need,” across the entire health journey.

Prescription 52

Prescription Medical Distribution Patients 52

World of DTC Marketing

MAY 9, 2022

Online ad fraud is costing pharma millions. Online Ad Stats : Social media advertising budgets are expected to grow 11.76% annually by 2026. It’s no wonder that DTC marketers continue to rely on TV ads, but with more money being used for digital, one has to wonder if pharma people understand what’s going on?

Pharma 208

Pharma Media Marketing Sales 208

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare.

FDA 52

FDA Prescription Medicine Biopharma 52

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards.

Pharma 113

Pharma Manufacturing Biopharma Healthcare 113